Premium DNA report providers from Prof. Roberto Grobman: Who we are? When we observed the incredible growth of scientific research after the completion of the genome project in 2003. Doctors and other health professionals were unable to update themselves with the millions of articles, results and conclusions published annually. Therefore, this information needed to be catalogued, filtered and transformed in some way to serve as a tool for health professionals. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. Discover even more details on Roberto Grobman.
Some pioneering hospitals have started to store pharmacogenomics reports and have integrated them within their clinical systems. This allows them, for example, to send an alert to the treating doctor and your pharmacist that says: ‘while we’re treating this person for X, please be aware, don’t use Y or Z because their pharmacogenetics test indicates alternatives with a potentially better outcome’. What does FullDNA DNA test for and how is it used? We test about 80 specific gene variants. These variants are only linked to exercise, nutrition and mental well-being (stress and sleep). No disease or diagnostic testing is involved — therefore people can really look at this as a way to help them improve their health and well-being.
Entry-level genetic report services with Prof. Roberto Grobman 2023: As results are provided directly to the individual, they are not in your insurance or medical record (unless you share results with your healthcare professional). It is often less expensive than genetic testing obtained through a healthcare provider, which can make testing more accessible to people with no or limited health insurance. DNA sample collection is usually simple and noninvasive, and results are available quickly. Your anonymous data is added to a large database that can be used to further medical research. Depending on the company, the database may represent up to several million participants.
Consider the example of familial hypercholesterolemia (FH), a condition in which multiple variants of several different genes lead to markedly high cholesterol. This greatly increases the risk of heart attack, stroke, and other health problems. FH affects about one in 300 adults, which means it isn’t rare. Among adults who have the most common genetic variants that cause it, heart attack or sudden cardiac death may occur in middle age. Children who have a double dose of a gene variant linked to this condition may die of cardiovascular disease before age 20. Earlier treatments intended to reduce the risk of complications, such as cholesterol-lowering drugs, are available if a child or adult is known to have a mutation linked to FH.
These tests can often allow doctors to see what’s going on that they may not be observing in a physical examination — things that don’t manifest in the body. But such hereditary and congenital diseases are rare. DNA is not destiny: People are complex, and there are many things that affect someone’s health and ability to be healthy — from environmental to genetic. Your DNA is saying who you are—– not what you can and can’t be. And that’s an important message. For example, Andrew Steel, a 400-metre runner and former Olympian, discovered that he didn’t have what is called ‘the sprint gene’, one of a pair of genes that almost all other Olympic sprinters have. Had he been told at an early age ‘you don’t have this gene, so you’ll never amount to anything in sport’, he may not have gone on to become an Olympic medal-winning runner. The example also demonstrates the importance of reputable advice on how to interpret the results of DNA health tests.
Our studies identified the relationship between Coronavirus and Genetics. We performed genetic analysis with more than 300 coronavirus patients in Brazil. We divided into 3 groups. A group of patients in the ICU in serious condition. A group with patients in the hospital but in a moderate state and a group with patients at home, with mild manifestation of the disease. We have a tool capable of predicting which individuals are at greater or lesser risk for the pandemic, and regarding vaccine risks. Discover even more details on Prof. Roberto Grobman.